Theraclion specializes in developping, manufacturing and marketing echotherapy equipment associating therapy with focused ultrasound (HIFU) and monitoring by ultrasound. The company provides Echopulse, a device for non-invasive and outpatient treatment of mammary fibroadenoma and thyroid nodules.Net sales break down by activity as follows: - sale of consumables (52.8%); - sale of equipment (28.8%); - provision of after-sales services (18.4%). The vast majority of net sales are earned abroad.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

Quotes

Date	Price	Change	Volume
26/10/26	EUR 0.6190	+5.27%	49,337
23/10/26	EUR 0.5880	+0.51%	44,086
22/10/26	EUR 0.5850	+8.33%	29,339
21/10/26	EUR 0.5400	+3.45%	37,353
20/10/26	EUR 0.5220	-8.10%	20,237

Real-time Euronext Paris

More quotes

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Theraclion

Company calendar

Market Closed - Euronext Paris 03:55:00 27/10/26 am AEDT			5-day change	1st Jan Change
0.6190 ^EUR	+5.27%		+8.98%	+2.82%

17/09	Theraclion SA Reports Earnings Results for the Half Year Ended June 30, 2026	CI
17/09	Theraclion widens its operating loss in the first half

Market Cap	45.25M 50.61M 41.87M 37.91M 70.95M 4.81B 72.11M 504M 199M 2.52B 190M 186M 7.97B	P/E 2024	-2.66x	P/E 2025	-6.33x
Enterprise Value	53.11M 59.39M 49.13M 44.49M 83.26M 5.65B 84.62M 591M 234M 2.96B 223M 218M 9.36B	EV / Sales 2024	22.5x	EV / Sales 2025	55.4x
Free-Float	32.52%	Yield 2024 *	-	Yield 2025	-

Markets		Quality
Euronext Paris	ALTHE	Real-time
Boerse Muenchen	941	Real-time
Börse Stuttgart	941	Delayed
Deutsche Boerse AG	941	Delayed
CBOE		Real-time
CBOE		Real-time

17/09	Theraclion SA Reports Earnings Results for the Half Year Ended June 30, 2026	CI
17/09	Theraclion widens its operating loss in the first half
24/07	Theraclion SA Reports Consolidated Revenue Results for the First Half Ended June 30, 2026	CI
09/07	Theraclion Announces Board Changes	CI
09/07	Theraclion Appoints New Chairman	MT
19/06	Claude Lenoir appointed interim chairman of Theraclion
19/06	Theraclion Chairman Steps Down; Interim Successor Named	MT
19/06	Theraclion Announces Board Changes	CI
09/06	Theraclion Secures AMA CPT Editorial Panel Approval For New Category III CPT Code For Sonovein	CI
05/06	Theraclion deploys first Sonovein system in China
05/06	Theraclion JV Deploys Sonovein System at Chinese Hospital	MT
05/06	Theraclion Announces First Clinical Deployment Of Sonovein In Hainan, China	CI
05/06	Theraclion Deploys Sonovein System At Boao Super Hospital in Hainan Province	CI

Theraclion Stock

Stocks

ALTHE

FR0010120402

Advanced Medical Equipment & Technology

Valuation: Theraclion

Chart: Theraclion

Latest news: Theraclion

Press Releases: Theraclion

News in other languages: Theraclion

Quotes and Performance

Price Extremes

Managers and Directors: Theraclion

Latest insider transactions

Other Advanced Medical Equipment & Technology

Financials

Company Profile

Quotes

Annual profits - Rate of surprise

17/09	2026 Half-Year Results: Theraclion Prepares for a New Stage in Its Development	BU
24/07	Theraclion Initiates Its Commercial Momentum in the First Half of 2026	BU
16/07	Theraclion: First Half 2026 Report on the Liquidity Contract With CRÉDIT INDUSTRIEL ET COMMERCIAL	BU
09/07	Theraclion Strengthens Its Governance by Appointing Vincent Gardès as Chairman of Its Board of Directors	BU
19/06	Theraclion Announces the Evolution of Its Board of Directors	BU

14/10	Bourse : ASML finit par convaincre, spéculation sur Big Yellow, Evotec séduit
14/10	Résultats en entrée, inflation en plat de résistance
14/10	Agenda Zonebourse des résultats de sociétés : le 14 octobre 2026
10/10	Agenda des résultats de la semaine : on va savoir pour LVMH, JPMorgan et quelques autres
17/09	Theraclion creuse sa perte d'exploitation au 1er semestre

1 day	+5.27%
1 week	+8.98%
Current month	-10.81%
1 month	-17.47%
3 months	+4.38%
6 months	+23.80%
Current year	+2.82%

1 week	0.52	0.62
1 month	0.51	0.75
Current year	0.4	0.93
1 year	0.4	0.93
3 years	0.14	1.25
5 years	0.14	1.7
10 years	0.14	6.3

Manager	Title	Age	Since
Martin Deterre CEO	Chief Executive Officer	-	24/05/2023
Julie Veisseire DFI	Director of Finance/CFO	-	-
Alexandra Rocher COO	Chief Operating Officer	-	-

Director	Title	Age	Since
Mehdi El Glaoui BRD	Director/Board Member	-	22/06/2021
Cédric Bellanger BRD	Director/Board Member	-	28/01/2022
Lijuan Deng BRD	Director/Board Member	-	29/06/2023

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
THERACLION	+5.27%	+8.98%	-8.97%	+30.32%	48.14M
THERMO FISHER SCIENTIFIC, INC.	+1.64%	+0.81%	+19.63%	+55.60%	249B
DANAHER CORPORATION	+1.07%	+3.81%	+4.47%	+20.29%	162B
INTUITIVE SURGICAL, INC.	-0.15%	+4.26%	-17.36%	+74.03%	157B
BOSTON SCIENTIFIC CORPORATION	-0.24%	+1.18%	-54.92%	-8.44%	66.22B
VEEVA SYSTEMS INC.	-1.50%	+0.44%	+8.59%	+67.34%	52.3B
SIEMENS HEALTHINEERS AG	+1.03%	+3.07%	-14.62%	-8.28%	52.18B
EDWARDS LIFESCIENCES CORPORATION	+1.67%	+3.83%	+19.00%	+44.25%	51.34B
AGILENT TECHNOLOGIES, INC.	+1.67%	+3.57%	+18.87%	+68.69%	48.79B
WATERS CORPORATION	+0.51%	+5.00%	+26.84%	+86.53%	44.57B
Average	+1.10%	+3.50%	+0.15%	+43.03%	88.35B
Weighted average by Cap.	+0.80%	+2.65%	+2.30%	+46.13%

	2024	2025
Net sales	830K 928K 768K 695K 1.3M 88.33M 1.32M 9.24M 3.66M 46.2M 3.48M 3.41M 146M	652K 729K 603K 546K 1.02M 69.37M 1.04M 7.26M 2.87M 36.28M 2.74M 2.68M 115M
Net income	-5.76M -6.44M -5.33M -4.82M -9.03M -613M -9.17M -64.1M -25.35M -320M -24.16M -23.65M -1.01B	-5.69M -6.36M -5.26M -4.77M -8.92M -605M -9.07M -63.35M -25.06M -317M -23.88M -23.37M -1B
Net Debt	3.41M 3.81M 3.16M 2.86M 5.35M 363M 5.43M 37.97M 15.02M 190M 14.32M 14.01M 601M	7.85M 8.78M 7.26M 6.58M 12.31M 835M 12.51M 87.42M 34.58M 437M 32.96M 32.25M 1.38B